Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05600621
Other study ID # R01MH131507
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 26, 2023
Est. completion date July 31, 2027

Study information

Verified date June 2024
Source Washington University School of Medicine
Contact Fred M Ssewamala, PhD
Phone 3149358521
Email fms1@wustl.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will test four economic empowerment intervention components to identify the combination that best enhance viral suppression. The study design is a 2-to-the 4 factorial experiment. The 2 represents the level of each component:0 (receive) or (don't receive) four components: 1) Financial Literacy Training (FLT); 2) Incentivized Matched Youth Savings Accounts (YSA) with income-generating activities (IGAs); 3) A manualized intervention for ART adherence and stigma reduction (Suubi Cartoon); and 4) Engagement with HIV treatment-experienced role models who share their lived experiences of HIV. Guided by the MOST framework, the study will test each of the four components' performance and their combinations on the primary outcome, viral suppression. Resulting in 16 unique conditions representing all possible combinations of the 4 components. The study will randomize at the level of health clinics (N=48). Clinics will be randomized to provide one of the 16 conditions, with 12 ALHIV (aged 11-17 years) enrolled per clinic, yielding main effects and interaction effects for the 4 components on sustained viral suppression. Sustained viral suppression is defined as an undetectable viral load on all 12-, 24- and 36-month follow-up assessments.


Description:

The number of adolescents living with HIV (ALHIV) in Uganda is over 170,000 and growing. Ugandan ALHIV are a priority due to social and structural inequities that make them highly vulnerable to HIV infection and sub-optimal access and adherence to antiretroviral therapy (ART). Less than 50% of ALHIV in Uganda are ART-adherent leading to low rates of viral suppression and high rates of attrition from HIV care. In response to the call for expanding differentiated care approaches for ALHIV and new forms of combination HIV interventions, we seek to intervene on social and structural inequities as economic and psychosocial hardships exacerbate the risk for viral load non-suppression. Addressing these hardships can improve the livelihoods of ALHIV and give them the knowledge and resources to sustainably manage HIV. With 15+ years of intervention research combining 1) economic empowerment (EE) and 2) psychosocial components for HIV prevention, care and support for adolescents in SSA, we have demonstrated the effectiveness of Suubi (Hope), our multi-component combination intervention tested in four RCTs in Uganda (R01HD070727, R01HD074949, R34MH081763, R01MH113486) and one foundation-funded study in Kenya. With EE components to address economic hardships and psychosocial components to address ART non-adherence and HIV stigma, we have improved viral suppression and psychosocial and mental health functioning. Suubi is evidence-based and theory-informed and has four components: 1) Financial Literacy Training (FLT); 2) Incentivized Matched Youth Savings Accounts (YSA) with income-generating activities (IGAs); 3) A manualized intervention for ART adherence and stigma reduction (Suubi Cartoon); and 4) Engagement with HIV treatment-experienced role models who share their lived experiences of HIV. Suubi has shown robust effects on viral suppression and ART adherence, mental health, psychosocial outcomes, and family financial stability and cohesion. However, it is unknown if each component in Suubi had a positive effect, how the components interacted, or if fewer components could have produced equivalent effects. Given our successes and infrastructure, we are well-positioned to unpack and optimize Suubi to identify the most impactful and sustainable components for scale up across Uganda. The study will use a factorial experiment to unpack, test, and optimize the Suubi intervention to enhance scale up in health systems using the multi-phase optimization strategy (MOST), an engineering-inspired intervention framework. Guided by the MOST framework, the study will test each of the four components' performance and their combinations in a fully powered efficient factorial experiment on the primary outcome, viral suppression. Then a pre-specified optimization objective will be set to create the new "optimized" intervention. We define our "optimization objective" as the most cost-effective components that addresses three real-world constraints (i.e., challenges to implementation): 1) efficiency (do the components work within our existing health systems?), 2) affordability (do observed effect sizes justify costs and labor?), and 3) scalability (do components perform exactly as they would at scale?). The study will evaluate various component combination effect sizes and balance them against real-world constraints and costing data to empirically arrive at optimization. Our goal is to build Suubi 2.0 (hereafter, Suubi+Adherence4Youth), a combination of components for viral suppression that meets standards for being efficient, affordable, and working at scale. The study will be guided by the following specific aims: Aim 1. Conduct a factorial experiment (optimization trial) to test the main effects of each of the four Suubi intervention components and combinations of components (interactions) on viral suppression (primary outcome); Aim 2. Test mediators and explore moderators that explain and modify the relationship between each of the four Suubi intervention components and viral suppression; Aim 3. Compare the cost and cost-effectiveness of each of the four Suubi intervention components and every combination of components.


Recruitment information / eligibility

Status Recruiting
Enrollment 576
Est. completion date July 31, 2027
Est. primary completion date July 31, 2027
Accepts healthy volunteers No
Gender All
Age group 11 Years to 17 Years
Eligibility Inclusion Criteria: Adolescent: - living with HIV (confirmed by medical report and aware of status) - living within a family - being 11-17 years of age (at enrollment) - prescribed ART - enrolled in ART care at one of the 48 health clinics in the study districts. Health clinics would be eligible if they: - have existing procedures tailored to adolescent adherence (including adolescent-specific clinic days and peer counselling) - Accredited by the Uganda Ministry of Health as a provider of ART within the study districts. Exclusion Criteria: - Includes an inability to understand study procedures and participant rights as assessed during informed consent/assent process with the adolescent or parent. - If the adolescent or adult caregiver presents with emergency needs (e.g., hospitalization), needed care will be secured, rather than study participation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Financial Literacy Training (FLT) Workshops
Participants will be assigned to receive FLT workshops which are implemented by community-level agencies in collaboration with the financial institutions. FLT comprises six workshops delivered over 6 weeks. Topics include: a) an introduction to the notion of asset-building; b) coverage of asset-building strategies in detail, e.g., saving; c) coverage of specific topics related to saving, e.g., the importance of saving and how to save, d) an introduction of banking services to participants and e) coverage of basics of borrowing and debt management. Participants from the same location, in this case, clinics are assigned to the same group. Workshops occur on weekends to accommodate participants week-day schedules, including school and/or gardening.
Incentivized Matched Youth Savings Accounts (YSA) with income-generating activities (IGAs)
ALHIV will receive a YSA with a 1:1 matched savings program at a financial institution accredited by the Bank of Uganda. Each YDA will be opened in the name of the adolescent, with their primary caregiver as a co-signer, until the adolescent turns 18 years. The account will then be matched with money from the program on 1:1 rate. As part of YSA, ALHIV are also trained on investing in income-generating activities (IGA) and are normally allowed to use up to 30% of their matched savings to invest in an IGA to benefit their family. The IGA portion helps promote economic stability for families and enable the ALHIV to afford medical expenses.
A manualized visual-based intervention for ART adherence and stigma reduction using multiple family group approach (Suubi Cartoon).
Participants assigned to this component will participate together with her/his caregiving family, in attending sixteen 60 minute sessions hosted within the community over 16 weeks. Each session involves 6-10 families. Participants will learn from the Suubi Cartoon curriculum about their HIV diagnosis and treatment needs, while coping with family loss, stigma, peer relationships, identity, and family functioning.
Engagement with HIV treatment-experienced role models who share lived experiences of HIV
Participants will be assigned to small groups with an average of 3-4 peers from the same health clinic, and each ALHIV stays in the same group -- for 9 sessions - with the same role model. This is intended to build trust and rapport not only between the role model and mentee, but also between all group members. The 9 sessions, to be conducted over a 6-month period, include activities, videos, scenarios, and role-playing to facilitate discussion and learning. This is intended to promote their self-esteem, improve their HIV care engagement, reduce stigma and stress, encourage hopefulness, build stronger communication skills with their caregivers and/or family members, enhance safe sexual decision-making, and decrease sexual risk-taking behavior.
Other:
Standard of Care (SOC)
SOC consisting of pediatric ART initiation and monitoring outlined by Uganda's Ministry of Health.

Locations

Country Name City State
Uganda International Center for Child Health and Development Masaka

Sponsors (3)

Lead Sponsor Collaborator
Washington University School of Medicine National Institute of Mental Health (NIMH), University of California, San Francisco

Country where clinical trial is conducted

Uganda, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in ART knowledge and ART adherence Change in adolescent Self reported medication adherence. This will be measured using the Adherence and retention in care questionnaire focusing on the pharmacy refills, pill counts and missed appointments at each assessment time. Baseline 12, 24 and 36 month follow-up
Other Reductions in internalized stigma Reductions in internalized stigma will be measured using the Social Impact Scale on a range of 24 - 96, with higher scores indicating higher levels of internalized stigma. Baseline 12, 24 and 36 month follow-up
Other Sexual negotiation and communication skills Ability to negotiate safe sex practices measured using the Sexual Communication Scale. Responses are summed and scored on a range of 20 - 100, with higher scores representing greater levels of communication. Baseline 12, 24 and 36 month follow-up
Other Change in mental health-hopelessness symptoms Hopelessness will be measured using the Beck Hopelessness Scale. The study will assess the mean scores over time. The total score range is between 0 - 20, with a higher score indicating higher levels of child hopelessness. Baseline 12, 24 and 36 month follow-up
Other Change in depressive symptoms Depression will be measured using the Center for Epidemiological Studies-Depression Scale (CES-D). The total score range is between 0 - 60, with higher scores indicating the presence of more symptomatology. Baseline 12, 24 and 36 month follow-up
Other Change in HIV Stigma Change in HIV stigma will be measured using the Negative Self-image sub-scale of HIV Stigma Scale. The total score range is between 40 - 160 with higher scores indicating higher levels of perceived HIV-associated stigma. Baseline 12, 24 and 36 month follow-up
Other Positive HIV Identity HIV Positive Identity Scale Baseline 12, 24 and 36 month follow-up
Other Problem solving of HIV care logistics Self-reported questionnaires Baseline 12, 24 and 36 month follow-up
Other Self-esteem Self esteem will be measured using Rosenberg Self-Esteem Scale. The study will assess the mean scores over time. The total score range between10 - 40, with a higher score indicating high levels of child self esteem. Baseline 12, 24 and 36 month follow-up
Other Social support Change in social support will be measured by Social Support Behavior Scale. Baseline 12, 24 and 36 month follow-up
Other Engagement and retention of HIV care metrics The degree to which a patient feels engaged/disengaged from HIV care will be measured using the HIV Index of Engagement on a range of 10 - 50, with higher scores indicating better engagement. Baseline 12, 24 and 36 month follow-up
Primary Achievement of Viral Suppression Change in viral suppression will be assessed using viral load (VL) data collected from health clinic records. VL will be dichotomized between undetectable /suppression (VL< 40 copies/ml) and detectable/failed viral suppression (VL > =40 copies/ml) levels at each assessment time. Baseline 12, 24 and 36 month follow-up
Primary Cost-Effectiveness Analyses Cost-effectiveness analyses measuring the cost of achieving an agreed upon benefit, such as cost of staff time, supplies, overhead of IDA's, as measured by admin review and project records. Baseline 12, 24 and 36 month follow-up
Secondary Financial Literacy Change in Financial Literacy knowledge will be measured using the Financial Literacy Knowledge item, with higher scores indicating higher financial literacy. Baseline 12, 24 and 36 month follow-up
Secondary Financial management skills Change in financial management skills will be measured using the Attitudes about Saving Scale, with higher scores indicating greater financial management skills. Baseline 12, 24 and 36 month follow-up
Secondary Engagement with financial institutions Change in engagement with financial institutions will be measured using the frequency of deposits and withdrawals by data from bank statements. Baseline 12, 24 and 36 month follow-up
Secondary Change in confidence to save Change in confidence to save will be measured using the Financial Literacy Knowledge item, with higher scores indicating higher confidence to save. Baseline 12, 24 and 36 month follow-up
Secondary Change in motivation to save Motivation to save will be measured using the Financial Literacy Knowledge item, with higher scores indicating higher motivation to save. Baseline 12, 24 and 36 month follow-up
Secondary Change in savings amount and Investment in IGA Change in savings amount and investment measured by data from bank statements Baseline 12, 24 and 36 month follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2